Home > Products > Pharmaceuticals & Life Science > API & Advanced Intermediates > Fulvestrant (ICI 182780) S enantiomer
Fulvestrant (ICI 182780) S enantiomer structure, CAS 1316849-17-8

Fulvestrant (ICI 182780) S enantiomer

CAS Number1316849-17-8

Synonyms

Molecular FormulaC32H47F5O3S

Molecular Weight606.77

Purity

Density

Boiling Point

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-3181949 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 1316849-17-8 ] SDS Specification MoL

Chemical & Physical Properties
CAS Number1316849-17-8
Catalog No.2A-3181949
Chinese Name氟维司群S对映体
Molecular FormulaC32H47F5O3S
Molecular Weight606.77
Storage Condition2-8℃
ApplicationFulvestrant S enantiomer is the S-enantiomer of Fulvestrant. Fulvestrant is a selective estrogen receptor (ER) antagonist useful in the treatment of breast cancer.
PubChem ID438442951
SMILESCC12CCC3c4ccc(O)cc4CC(CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)C3C1CCC2O
InChIInChI=1S/C32H47F5O3S/c1-30-17-15-26-25-12-11-24(38)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-41(40)19-9-16-31(33,34)32(35,36)37/h11-12,21-22,26-29,38-39H,2-10,13-20H2,1H3/t22-,26-,27+,28?,29+,30-,41+/m1/s1
InChI KeyVWUXBMIQPBEWFH-JSEPIYAZSA-N
Transport InfoProduct Name: Fulvestrant S enantiomer
Related Products in API & Advanced Intermediates
7β-Fulvestrant407577-53-12A-3181912
ipilimumab477202-00-92A-0202043
Nivolumab946414-94-42A-2181932
mepolizumab196078-29-22A-2181939
Fulvestrant 9-Sulfone98008-06-12A-3181947
Fulvestrant (ICI 182780) R enantiomer1807900-80-62A-3181950
1,2-Dihydro Fluticasone Propionate105613-90-92A-3181957
DesfluoroMethyl Fluticasone Propionate Disulfide201812-64-82A-3181958
Imatinib Meta-methyl-piperazine Impurity1246819-59-92A-3181968
iMatinib related substance B571186-93-12A-3181969
Browse all API & Advanced Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA